Skip to main content
SpringerLink
Log in

Phase I results support ocular safety of mirabegron

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Martin N, Lewis RA, Vogel R, Sheth N, Sargent B, Swearingen D, Rasmussen S, Hantsbarger G, Novack GD.Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects. 27th Congress of the European Association of Urology: abstr. 686, 24 Feb 2012. Available from: URL: http://www.uroweb.org/events/abstracts-online/?aid=37998

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phase I results support ocular safety of mirabegron. React. Wkly. 1394, 2 (2012). https://doi.org/10.2165/00128415-201213940-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00004

Keywords

Search

Navigation